0

Journal Articles

in Thromboembolism/Anticoagulation
 61-80 of 766 Articles
JAMA | 
Viewpoint |  September 05, 2012
The Safety Risks of Innovation:  The FDA's Expedited Drug Development Pathway
Thomas J. Moore, AB; Curt D. Furberg, MD, PhD
JAMA. 2012;308(9):869-870. doi:10.1001/jama.2012.9658.
JAMA Internal Medicine | 
Editorial |  August 13, 2012
Overdiagnosis of Disease:  A Modern Epidemic
Jerome R. Hoffman, MA, MD; Richelle J. Cooper, MD, MSHS
Arch Intern Med. 2012;172(15):1123-1124. doi:10.1001/archinternmed.2012.3319.
JAMA | 
From the Centers for Disease Control and Prevention |  August 08, 2012 FREE
Venous Thromboembolism in Adult Hospitalizations—United States, 2007–2009
JAMA. 2012;308(6):559-561. doi:.
JAMA Internal Medicine | 
Brief Report |  July 09, 2012
Evaluation of Pulmonary Embolism in the Emergency Department and Consistency With a National Quality Measure:  Quantifying the Opportunity for Improvement
Arjun K. Venkatesh, MD, MBA; Jeffrey A. Kline, MD; D. Mark Courtney, MD; et al.
Arch Intern Med. 2012;172(13):1028-1032. doi:10.1001/archinternmed.2012.1804.
JAMA Neurology | 
Images in Neurology |  July 01, 2012
Atypical Cerebral Venous Thrombosis:  Magnetic Resonance Imaging and Spectroscopy Features
Duško Kozić, PhD; Vesna Njagulj, MD; Jelena Ostojić, PhD; et al.
Arch Neurol. 2012;69(7):930-931. doi:10.1001/archneurol.2011.2542.
JAMA | 
Editorial |  June 27, 2012
Cerebral Hemorrhage, Warfarin, and Intravenous tPA:  The Real Risk Is Not Treating
Mark J. Alberts, MD
JAMA. 2012;307(24):2637-2639. doi:10.1001/jama.2012.7265.
JAMA Internal Medicine | 
Research Letters |  June 25, 2012
Trends in In-Hospital Deaths Among Hospitalizations With Pulmonary Embolism
James Tsai, MD, MPH; Scott D. Grosse, PhD; Althea M. Grant, PhD; et al.
Arch Intern Med. 2012;172(12):960-961. doi:10.1001/archinternmed.2012.198.
JAMA Internal Medicine | 
Special Article |  June 25, 2012
The Diagnosis and Treatment of Pulmonary Embolism:  A Metaphor for Medicine in the Evidence-Based Medicine Era
Vinay Prasad, MD; Jason Rho, MD; Adam Cifu, MD
Arch Intern Med. 2012;172(12):955-958. doi:10.1001/archinternmed.2012.195.
JAMA | 
Viewpoint |  June 20, 2012
Clopidogrel Efficacy and Cigarette Smoking Status
Paul A. Gurbel, MD; Thomas D. Nolin, PharmD, PhD; Udaya S. Tantry, PhD
JAMA. 2012;307(23):2495-2496. doi:10.1001/jama.2012.5930.
JAMA Internal Medicine | 
Editor's Correspondence |  May 28, 2012
Dabigatran and Myocardial Infarction: Meta-Illusion?
Arch Intern Med. 2012;172(10):823. doi:10.1001/archinternmed.2012.836.
JAMA Internal Medicine | 
Editor's Correspondence |  May 28, 2012
Dabigatran and Myocardial Infarction: Meta-Illusion?—Reply
Arch Intern Med. 2012;172(10):823. doi:10.1001/archinternmed.2012.1154.
JAMA | 
Original Contribution |  May 02, 2012 FREE
Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction:  The INFUSE-AMI Randomized Trial
Gregg W. Stone, MD; Akiko Maehara, MD; Bernhard Witzenbichler, MD; et al.
JAMA. 2012;307(17):1817-1826. doi:10.1001/jama.2012.421.
JAMA Neurology | 
Images in Neurology |  May 01, 2012
Severe Decrease in Cerebral Blood Volume, Recanalization, and Hemorrhagic Transformation After Thrombolysis
Tae-Hee Cho, MD; Laura Mechtouff, MD; Laurent Derex, MD, PhD; et al.
Arch Neurol. 2012;69(5):666. doi:10.1001/archneurol.2011.2327.
JAMA Internal Medicine | 
Invited Commentary |  April 23, 2012
A New Era in Stroke Prevention for Atrial Fibrillation:  Comment on “Current Trial-Associated Outcomes With Warfarin in Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation
Daniel E. Singer, MD; Alan S. Go, MD
Arch Intern Med. 2012;172(8):631-633. doi:10.1001/archinternmed.2012.897.
JAMA Internal Medicine | 
Review Article |  April 23, 2012 FREE
Current Trial-Associated Outcomes With Warfarin in Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation:  A Meta-analysis
Shikhar Agarwal, MD, MPH, CPH; Rory Hachamovitch, MD, MS; Venu Menon, MD
Arch Intern Med. 2012;172(8):623-631. doi:10.1001/archinternmed.2012.121.
INCLUDES: CME
JAMA Internal Medicine | 
Invited Commentary |  March 12, 2012
Dabigatran: Do We Have Sufficient Data?:  Comment on “Dabigatran Association With Higher Risk of Acute Coronary Events”
Jeremy M. Jacobs, MBBS; Jochanan Stessman, MD
Arch Intern Med. 2012;172(5):403-404. doi:10.1001/archinternmed.2011.1721.
JAMA Internal Medicine | 
Review Article |  March 12, 2012 FREE
Dabigatran Association With Higher Risk of Acute Coronary Events:  Meta-analysis of Noninferiority Randomized Controlled Trials
Ken Uchino, MD; Adrian V. Hernandez, MD, PhD
Arch Intern Med. 2012;172(5):397-402. doi:10.1001/archinternmed.2011.1666.
INCLUDES: CME , Supplemental Content
JAMA Surgery | 
Special Feature |  March 01, 2012 FREE
Image of the Month—Diagnosis
Arch Surg. 2012;147(3):292. doi:10.1001/archsurg.147.3.292.
JAMA Surgery | 
Original Article |  February 01, 2012 FREE
Increased Risk of Postoperative Deep Vein Thrombosis and Pulmonary Embolism in Patients With Inflammatory Bowel Disease:  A Study of National Surgical Quality Improvement Program Patients
Andrea Merrill, MD; Frederick Millham, MD
Arch Surg. 2012;147(2):120-124. doi:10.1001/archsurg.2011.297.
INCLUDES: CME , Supplemental Content
JAMA Surgery | 
Invited Critique |  February 01, 2012
Use of National Surgical Quality Improvement Program Outcomes Data to Change Guidelines: A Sound Idea?:  Comment on “Increased Risk of Postoperative Deep Vein Thrombosis and Pulmonary Embolism in Patients With Inflammatory Bowel Disease”
Laura E. White, MD; Heitham T. Hassoun, MD
Arch Surg. 2012;147(2):124. doi:10.1001/archsurg.2011.1036.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  April 1, 2013
Use of Glucocorticoids and Risk of Venous Thromboembolism:  A Nationwide Population-Based Case-Control Study
Sigrun A. Johannesdottir, BSc; Erzsébet Horváth-Puhó, MSc, PhD; Olaf M. Dekkers, MD, PhD, MSc, MA; et al.
JAMA Internal Medicine
In This Issue of JAMA Internal Medicine  |  May 13, 2013
In This Issue of JAMA Internal Medicine
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?
Kristian B. Filion, PhD; Jonathan Assayag, MSc; Laurent Azoulay, PhD
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply
Daniel M. Witt, PharmD; Thomas Delate, PhD; Mark A. Crowther, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems